Prosecution Insights
Last updated: October 25, 2026

Charles River Laboratories Inc.

Technology areas: Biotechnology & Pharmaceuticals • Communications

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Charles River Laboratories Inc. currently has 2 pending office actions within the Communications technology area. These matters are assigned to 2 distinct examiners. The prosecution activity is distributed across distinct art units. These figures indicate that the company's active matters are spread among multiple reviewers and administrative divisions. This distribution provides a variety of examiner perspectives within the Communications sector.

GARCIA, GABRIEL I is the busiest examiner for the company and is responsible for 1 pending office action. This busiest examiner pending count of 1 is less than the total count of pending office actions. Because the workload is split, the company's prosecution success does not depend on a single examiner. Practitioners must manage different examination styles across the distinct examiners and art units. This arrangement requires a strategy that accounts for the specific requirements of each assigned reviewer. The current prosecution profile is characterized by this distribution of matters across the staff.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
50% of docket
0
Information Tech
0% of docket
1
Communications
50% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
GARCIA, GABRIEL I 1 90.4% +6.2%
JADHAO, SAMADHAN JAISING 1 46.2% +47.0%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18487284 AUTOMATED ENUMERATION SYSTEM GARCIA, GABRIEL I —
17627170 RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS HELPER VECTORS AND THEIR USE TO IMPROVE THE PACKAGING EFFICIENCY OF RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS JADHAO, SAMADHAN JAISING —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
17627170 RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS HELPER VECTORS AND THEIR USE TO IMPROVE THE PACKAGING EFFICIENCY OF RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS JADHAO, SAMADHAN JAISING —

Top Art Units

Art UnitApps
2682 1
1672 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18487284 AUTOMATED ENUMERATION SYSTEM GARCIA, GABRIEL I 2682 §102§103 Non-Final OA — Pending Oct 16, 2023
17627170 RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS HELPER VECTORS AND THEIR USE TO IMPROVE THE PACKAGING EFFICIENCY OF RECOMBINANTLY-MODIFIED ADENO-ASSOCIATED VIRUS JADHAO, SAMADHAN JAISING 1672 §102§103Other Non-Final OA — Pending Jan 14, 2022

Managing Charles River Laboratories Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Charles River Laboratories Inc. have?

Charles River Laboratories Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Charles River Laboratories Inc. applications?

Gabriel I Garcia has the most, with 1 of Charles River Laboratories Inc.'s pending office actions.

What technology area are Charles River Laboratories Inc.'s patent applications in?

Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month